SciClone Pharmaceuticals, Inc. (SCLN) Announces Presentations of SCV-07 Data at Upcoming Medical Meetings
11/13/2009 9:56:17 AM
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) Q3 Tops Estimates, Raises '09 View
11/9/2009 6:37:38 AM
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) to Cut 17% US Jobs, Take Related Charge
10/28/2009 7:15:43 AM
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) Announces Enrollment of First Patient in Its Phase 2 Trial of SCV-07 in Hepatitis C
10/21/2009 11:26:27 AM
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) (JOBS) Drops Cancer Drug Development
10/5/2009 6:50:13 AM
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) to Present at Two September Investor Conferences
9/9/2009 1:26:31 PM
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) to Present at the Rodman & Renshaw Annual Global Investment Conference
9/8/2009 11:04:43 AM
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) Reports Financial Results and Provides Pipeline Update for the Second Quarter of 2009
8/5/2009 11:09:57 AM
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference
8/3/2009 10:21:33 AM
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) Announces Appointment of Jon S. Saxe as Chairman of Board of Directors
7/31/2009 11:02:58 AM
More...
|
|